Exploration of multivariate curve resolution- alternating least squares (MCR-ALS) for datamining kinetically evolving...

Area of Science:

• Biophysics
• Spectroscopy
• Chemometrics

Background:

• Cellular Raman spectroscopy generates complex, kinetically evolving spectral data.
• Traditional methods like PCA and PLS-DA capture metabolic changes but lack detailed spectral resolution.
• Multivariate curve resolution-alternating least squares (MCR-ALS) is a chemometric technique for resolving mixed spectral signals.

Purpose of the Study:

• To evaluate the MCR-ALS approach for datamining complex spectral fingerprints from time-resolved cellular Raman spectroscopy.
• To investigate the impact of initial spectral component estimation and equality constraints on MCR-ALS performance.
• To determine optimal strategies for analyzing dynamic cellular metabolic processes using spectral data.

Main Methods:

• Application of MCR-ALS to cellular Raman spectroscopy data under control, stimulation, and inhibition conditions.
• Generation and analysis of simulated datasets to assess MCR-ALS resolution limits.
• Comparison of quantitative and qualitative analysis strategies, including initial estimate constraints and kinetic hard modeling.

Main Results:

• MCR-ALS struggled with accurate quantitative resolution of spectral components, especially with high cellular background.
• Simulated data highlighted the critical role of initial spectral component estimation in MCR.
• A qualitative analysis using MCR initial estimates and ALS kinetic constraints proved effective for complex cellular spectra.
• Resolved spectral fingerprints of both glycolytic and non-glycolytic cellular processes were identified across conditions.

Conclusions:

• MCR-ALS, when combined with appropriate constraints (initial estimates and kinetic models), offers valuable insights into dynamic cellular processes via label-free Raman spectroscopy.
• The study identified limitations in quantitative accuracy but demonstrated the potential for qualitative analysis in complex biological systems.
• This spectralomics approach shows promise for applications in drug screening, diagnostics, and bioprocess monitoring.